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Dear Editor,
We read your recent article Optimal timing of HIV home-
based counselling and testing rounds in Western Kenya [1] with
considerable interest. The authors make questionable assump-
tions about their modelled reference campaign in which 90%
of the population is reached, of these 60% of those contacted
are linked to care, and of these only 75% receive the CD4
count test required to access ART. Of people on ART, 86%
are virally suppressed, and of these 95.5% are retained at one
year and only 88% after four years. Therefore, the proportion
of people living with HIV (PLHIV) in community who are
virally suppressed for the first year can be derived by multi-
plying the parameters: diagnosed (90%), linked (60%), lab
tested (75%), virally suppressed (86%) and retained at one
year (95.5%). Using these parameters, the denominator rapidly
decreases and the percentage of HIV-positive people that are
virally suppressed after a year is about 30% and it declines
thereafter. Using these parameters results in an ineffective
and inefficient treatment programme at a substantial cost. The
article then asks what the optimal timing would be if it
were to be repeated? Given the poorly performing pro-
gramme, one answer is that it should first be significantly
improved before considering the question of how often it
should be repeated.
There are many examples of well-performing programmes
and successful interventions. For example, the 2008 private-
public sector collaboration involving the Kenya Ministry of
Health, Centers for Disease Control, CHF International, and
Vestergaard Frandsen showed that an effective community-
based multi-disease prevention campaign in Western Kenya
was able to reach and test 87% of its target population over a
seven days period [2]. By offering long-lasting insecticide-trea-
ted bed nets, water filters and rapid HIV testing they reached
47,311 people with a 96% uptake of the multi-disease preven-
tion package with 99.7% accepting HIV testing including
18,101 (38%) men. Of participants, 80% had never been
tested and 4% were diagnosed with HIV. The campaign also
reached people with higher CD4 cell counts probably earlier
in their HIV disease [2,3]. The more recent SEARCH study in
Uganda and Kenya has also reached very high proportions of
the community with testing of 131,307 (89%) of and success-
ful treatment with minimal loss to follow-up [4,5]. These pro-
grammes and recent results from population-based incidence
studies offer further evidence that expanding access to well-
designed and implemented HIV services can achieve remark-
able impact [6-10].
On closer examination the model in the article examines the
utility of repeating a failing home-based counselling and testing
(HBCT) programme when compared to more successful models.
HBCT programmes that reach 90% of its intended target are
expected, but a programme that can only put 60% on treatment
clearly has major problems that require urgent redress. The
subsequent 55% losses due to unnecessary waits for CD4 cell
counts and other service delivery problems further reduce the
overall percentage on treatment and suppressed. Perhaps most
worrisome about the modelled programme is the assumption
that no one who is lost to follow-up returns.
Despite considerable and effort to reach people in their
homes, the combined result is that the model projects that
only around 30% of PLHIV are successfully diagnosed, treated
and virally suppressed. Additionally, the cost of treatment is
$367 which is very expensive given the poor performance and
the current annual costs of around $75 per year for ARVs
alone. In many programmes these avoidable high costs and
low performance measures would be a sign of failure and indi-
cate the need for significant revision in service delivery to
prevent avoidable illnesses, deaths and HIV infections. Specifi-
cally, interventions to improve performance that other suc-
cessful programmes have used include same-day treatment
without delays for unnecessary laboratories, immediate social
support for patients starting treatment, routine use of viral
load for monitoring success and motivating patients, a highly
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tolerable dolutegravir-based regimen, and the use of cohort
monitoring with field support to ensure that people who are
lost do not stay so permanently.
It is important to build models using past performance
and costs but, in this case, it appears that the proposed pro-
gramme would need to be significantly revised or perhaps
even stopped until proper policies and quality assurance sys-
tems can be put in place. The questionable parameterization
leaves the reader in the dark regarding the potential benefits
of a well-functioning programme combined with multiple mul-
ti-disease prevention campaigns. The projected health impact
and economic savings of this sort of frontloaded approach
are considerable and have been discussed elsewhere [3,11].
It is likely that diagnosing and offering sustained successful
treatment to most of the people living in the community
would effectively extinguish the epidemic. There would be a
need for long-term treatment to keep PLHIV healthy and
non-infectious. With most people on treatment the pro-
gramme could then focus efforts on active case management,
reaching partners with HIV self-tests and services, and other
targeted prevention efforts for the rare HIV transmissions in
the community. The value of effectively reaching 95-95-95,
HIV elimination and ending AIDS [12] in the community is
difficult to state with certainty but is important to consider.
Science and experience support modelling focused on deter-
mining the impact of well-functioning programmes that
rapidly scale access to proven HIV services including early
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